Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150028/S007

CP Stent (Model 425), Covered CP Stent (Model 427), Mounted CP Stent (Model 426), Covered and Mounted CP Stent (Model 42

NuMED, Inc. · Decision date Jul 6, 2026

FDA DECISIONP150028/S007

What did the FDA approve?

FDA records P150028/S007 as a supplement to PMA P150028, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jul 6, 2026.

FDA approval order statement

approval for a manufacturing site located at Sterigenics U.S., LLC, 84 Park Road, Queensbury, NY 12804 as a contract sterilization facility, and modifications to reduce the ethylene oxide concentration at the existing contract sterilization facility at Cosmed Group (Lynx Medical) at 2205 East 33rd Street, Erie, PA, 16510
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Jul 6, 2026
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150028/S007
Regulatory pathway
PMA supplement
Applicant
NuMED, Inc.
Product code
PNF
Decision code
APPR
Decision date
Jul 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic stent.

Applicant
NuMED, Inc.
Product code
PNF
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P150028/S007 received

    Application receipt date recorded by FDA.

  2. P150028/S007 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P150028. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code PNF

Product / regulatory recordCompanyPathwayDecision dateSource
Renata Medical, Inc.PMA supplementAug 27, 2026FDA
Renata Medical, Inc.PMA supplementJul 9, 2026FDA
Renata Medical, Inc.PMA supplementFeb 11, 2026FDA
Renata Medical, Inc.PMA supplementDec 18, 2025FDA
Renata Medical, Inc.PMA supplementSep 11, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

NuMED, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2880 Main St., Hopkinton, NY, 12965

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records